Heron Therapeutics Inc. (HRTX)

[ARBITRARY & CAPRICIOUS]

Don't see much downside of holding through. The 5% chance of a class 1 CRL which will be rapidly corrected would limit downside if one believes its possible to even get another CRL. The drug is proven safe & effective indisputably with the QT study. I do believe this gets approved and word will be out tomorrow. If not, shame on both the FDA and company if they couldn't work through the process successfully to bring relief to so many cancer pts. when its not a matter of safety or efficacy, and can only be a minor manufacturing or delivery hangup. I will be extremely surprised with another CRL....not in this case.....no way at this junction....